ResearchSafe

GDF-11 cachexia risk at higher doses, anyone looked into the actual safety data?

Posted by kenji_runs in Safety & Side Effects - 5 points, 6 comments.

Been reading up on gdf-11 (/peptides/gdf-11) and honestly the anti-aging angle sounds brilliant on paper, brain and cardiac rejuvenation, muscle stem cell activation, all that. But the side effect profile lists cachexia risk at high doses and theoretical cancer risk from the tgf-b signalling pathway. That second one honestly makes me a bit nervous.

Like, tgf-b superfamily members are involved in tumour suppression AND tumour progression depending on context right? So stimulating that pathway systemically seems like it could go either way. Has anyone actually dug into whether there's any human safety data at all or is it all mouse/parabiosis stuff?

The dose range listed is 0.1-0.5 mg/kg daily which is a pretty wide window. Reckon the cachexia thing is more of a upper-end issue? I'd be keen to hear from anyone who's run it and what they noticed for body weight, appetite, bloodwork markers.

Also wondering if anyone has thoughts on whether running something anti-inflammatory alongside it would blunt the effects or if that's irrelevant to the mechanism. Cheers for any input, just trying to get my head round the risk side before even considering it.

Comments

  • tracker_jade: The TGF-b cancer thing is exactly why I backed off looking into GDF-11 seriously. Anecdotally, I've seen people in other communities hand-wave it as "theoretical" but that pathway is genuinely context-dependent in oncology literature, and nobody can tell you which context your tissue is in. That's not a minor footnote. The cachexia concern at the upper end makes sense to me mechanistically since myostatin is in the same superfamily and we know what that does to muscle at high signaling. But I'd
  • quinn636: Yeah, the TGF‑b cancer roulette is why I stick to watching cat videos instead of injecting mystery peptides. Cachexia? Sure, if you want to lose weight the hard way. Anyone actually seen human data or just mouse memes?
  • sleep_coastal: Agree completely on the TGF-b thing being the bigger concern. Anecdotally, I looked into GDF-11 a while back and the cachexia risk seemed dose-dependent and somewhat manageable. But the cancer question is a coin flip you can't really control. The same pathway that suppresses early tumors can promote metastasis later. That's not something you hedge with a lower dose.
  • kenji_runs: Honestly that coin flip part is exactly what has me stuck. If you cant hedge against the metastasis risk with a lower dose then the whole thing feels a bit dodgy for long term use. Did you see any specific studies on that dose-dependency you mentioned? I am curious if there is a clear threshold where weight loss starts or if it is just a gradual thing.
  • kenji_runs: Honestly i feel you on the cancer roulette bit. It is a bit of a gamble when the signalling is that complex. I haven't found a single human trial that isn't basically a glorified mouse study, which is frustrating. Do you reckon the cachexia risk is just a byproduct of the metabolism shift or is it more about actual muscle wasting? I'm trying to find if anyone has tracked their actual weight vs calorie intake.
  • kenji_runs: Yeah that is exactly what i am worried about. The fact that people just call it theoretical is a bit rubbish when we are talking about oncology. I havent found any actual human safety data yet, just a lot of parabiosis studies with old mice which doesnt tell me much about my own risks. Honestly i reckon the cachexia is just a sign of the signalling getting too heavy, but the cancer stuff is the real dealbreaker.

Community discussion - research and educational context only. Not medical advice.